Jacobo Sabbaj

Statistics

Publications

Citations

360

H-Index

Active since

1969

Affiliations

Merck Biopharma Co., Ltd. (Japan)(Current)

Jacobo Sabbaj is an author at Merck Biopharma Co., Ltd. (Japan) specializing in medical microbiology, antimicrobial pharmacotherapy, and infectious diseases.

Publications per year

1969–1988

Publications

Use of Norfloxacin to Treat Chronic Typhoid Carriers

Eduardo Gotuzzo, Jorge Guerra, Luis Benavente et al. · The Journal of Infectious Diseases · 1988 · 78 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +7

Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections

Jacobo Sabbaj, Vicki Hoagland, W J Shih · Antimicrobial Agents and Chemotherapy · 1985 · 73 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.

Jacobo Sabbaj, Vicki Hoagland, Terry Cook · PubMed · 1986 · 60 citations

Medicine, Pharmacology, Urology +11

Comparison of Selective Media for Isolation of Presumptive Group D Streptococci from Human Feces

Jacobo Sabbaj, Vera L. Sutter, Sydney M. Finegold · Applied Microbiology · 1971 · 42 citations · Full text

Life Sciences, Microbiology, Bacteriology +9

World-wide clinical experience with norfloxacin: efficacy and safety.

Chong Wang, Jacobo Sabbaj, Michelle M. Corrado et al. · PubMed · 1986 · 35 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +11

1–5 of 8